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A B S T R A C T
Background: Despite advances in treating epilepsy, uncontrolled epilepsy continues to be a major clinical
problem. Therefore, this work aimed to study the epidemiology of uncontrolled epilepsy in Al-Kharga
District, New Valley.
Methods: This study was carried out in 3 stages via door-to-door screening of the total population
(62,583 persons). All suspected cases of epilepsy were subjected to case ascertainment, conventional
ElectroEncephaloGraphy (EEG), and the Stanford-Binet Intelligence Scale. Patients who had been
receiving suitable anti-epileptic drugs (AEDs) over the previous 6 months and were having active
seizures were considered uncontrolled, according to Ohtsuka et al.23 The patients underwent serum AED
level estimation, video EEG monitoring, and brain MRIs. Fifty age- and gender-matched patients with
controlled epilepsy were chosen for statistical analysis and compared with true intractable patients.
Results: A total of 437 patients with epilepsy were identiﬁed, 30.7% of whom (n = 134/437) were
uncontrolled, with a prevalence of 2.1/1000. A total of 52.2% of uncontrolled patients (n = 70/134) were
inappropriately treated, while 47.8% (n = 64/134) were compliant with appropriate treatments. Video
monitoring EEG of compliant uncontrolled patients demonstrated that 78.1% patients (n = 50/64) had
deﬁnite epilepsy, while 21.9% (n = 14/64) had psychogenic non-epileptic seizures (PNES). A logistic
regression analysis revealed that status epilepticus, focal seizures, and mixed seizure types were risk
factors for intractability.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy is a common neurological disorder affecting 4–10/
1000 of the population.18,25 Although the prognosis for the
majority of patients is good,16 up to 30% of patients do not
experience remission despite appropriate therapy with antiepi-
leptic drugs.7,26 This situation has substantial deleterious effects
on patient health and quality of life and places a heavy burden on
society.11 The proportion of patients with intractable epilepsy
among the Egyptian population is currently unknown. Thus,
epidemiological data are important not only to improve our
understanding of the condition but also to allow a rational* Corresponding author at: Department of Neurology & Psychiatry, Assiut
University Hospitals, PO Box 71516, Assiut, Egypt. Tel.: +20 088 2350833;
fax: +20 088 2351838.
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http://dx.doi.org/10.1016/j.seizure.2013.04.010approach in planning health services.30 The early prediction of
intractability would be valuable because earlier identiﬁcation of
patients at highest risk would allow physicians to consider these
patients earlier for treatment with recently approved medications
and other surgical and non-surgical approaches.5 Therefore, we
conducted this work to study the prevalence of patients with
intractable seizures and to detect the predictors of intractability.
2. Subjects and methods
2.1. Study area
This study involved the population of Al-Kharga District (New
Valley Governorate). Geographically, the New Valley represents
approximately 44% of Egypt. It is divided into 3 oases; Al-Kharga
(the capital), Al-Farafra and Al-Dakhla districts. This area is far
removed from Nile Valley and has different geographical (oases in
the western Egyptian desert with hot dry weather, mainly
depending on the underground water supply), social (mainlyvier Ltd. All rights reserved.
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economy focuses mainly on dates) and cultural characteristics
(superstition relating epilepsy to evil attacks). It is also far from
well-developed health centres in Cairo and Assiut city.
2.2. Ethics
The Regional Ethics Committee of Assiut University approved
this study. Informed written consent was obtained from the Health
Institute and from each patient or their guardians.
2.3. Sample size
This study involved everyone (n = 62,583, 32,165 [51.4%] males,
30,418 [48.6%] females) living in the Al-Kharga District at the time
of the study and had been for at least 6 months.
2.4. Case deﬁnitions and classiﬁcation
Index cases were individuals who have been living in Al-Kharga
district at the time of interview for at least 6 months and diagnosed
with epilepsy (active epilepsy, epilepsy in remission, or well
controlled epilepsy).
Epilepsy was deﬁned as the occurrence of two or more
unprovoked seizures at least 24 h apart.17
Well controlled epilepsy was deﬁned as having achieved at least 2
years seizure free with or without treatment prior to the
interview.20
Medically uncontrolled epilepsy: because there is no agreed upon
deﬁnition, uncontrolled epilepsy was deﬁned here, according to
Ohtsuka et al.,23 as an average seizure frequency of one or more per
month during the last 6 months despite optimal and suitable use of
AED. This deﬁnition was used (because of the lack of accurate diary
registration of seizures) to overcome problems in accurately
recalling seizure dates beyond that period and to provide a good
opportunity to manage patients who were on inappropriate
treatment and those who were previously misdiagnosed with
psychogenic non-epileptic seizures.
Pseudo intractable epilepsy is deﬁned here as failure to achieve
seizure control during the last 6 months because of non-
compliance, inadequate AEDs doses, inappropriate AED(s) pre-
scriptions, and/or psychogenic non-epileptic seizures.
3. Method
The present work was a part of an extended project designed to
study the epidemiology of major neurological disorders, (stroke,
dementia, epilepsy, extrapyramidal syndromes, ataxia, cerebral
palsy, Bell’s palsy, and nocturnal enuresis) in Al-Kharga District,
New Valley, Egypt.12 The study was conducted in a door-to-door
survey (including every door) in three stages from June 1, 2005 to
May 31, 2008. During the ﬁrst stage, all households in Al-Kharga
district were screened by three neurologists to identify any
suspected case of epilepsy (as well as suspected cases of the
previously mentioned studied neurological disorders). They were
accompanied by 15 female social workers to collect the
demographic data. The screening was performed using a standar-
dised questionnaire, which was designed in Arabic (native
language) and speciﬁcally prepared for this study (sensitivity
93.2%, speciﬁcity 96%). After providing informed consent, and on
behalf of the family, the head of the household and his wife (or
responsible family member) were interviewed and asked about
themselves and all family members. Adults were interviewed
personally, and children, handicapped persons and the elderly
were interviewed through their responsible family members.
Epilepsy screening was carried out through inquiry about anyparoxysmal attacks of loss of consciousness, losing contact with
one’s surroundings, or involuntary shaking movements or con-
vulsions (or abnormal sensation) involving the arm(s) and/or leg(s)
or face. In the second stage, all suspected patients with epilepsy
(responding positively to any question in the screening question-
naire) were invited to attend Al-Kharga general hospital and/or
Assiut university hospitals where documentation of the diagnosis
was performed by 3 additional neurology staff members with
specialised training in recognising and treating epilepsy. There, the
patients were subjected to detailed history taking and full
neurological and physical evaluations. Source of information: data
were obtained by directly interviewing the patient and with a
seizure witness. In the third stage, all patients with the probable
diagnosis of epilepsy were invited to attend Assiut University
hospitals to perform conventional EEG record and psychometric
assessment of IQ using a standardised and validated Arabic
version22 of the Stanford-Binet Test (version IV).10 The Stanford-
Binet Intelligence Test is a standardised test that assesses IQ and
cognitive abilities in children and adults. It scores 15 sub tests,
including vocabulary, comprehension, verbal absurdities, pattern
analysis, matrices, paper folding and cutting, copying, quantitative,
number series, equation building, memory for sentences, and
memory for digits, objects, and beads. Intelligence was classiﬁed
according to Melika22 as follows: genius (IQ > 132), excellent
intelligence (IQ 121–131), above average (IQ 111–120), average
intelligence (IQ 89–110), below average (IQ 79–88), slow learner
(IQ 68–78), and mentally subnormal (IQ < 67). Estimation of
serum level of AEDs was done for those with probable medically
uncontrolled seizures to ensure adequate dose compliance. Video
EEG monitoring, using Nicolet machine version 5.1 with Windows
NT software, was performed for patients whose serum AED levels
were within the therapeutic ranges but still had medically
uncontrolled seizures (n = 64). The recording duration was at least
8 h while awake and 8 h while sleeping, and it was extended for
patients with infrequently repeated paroxysms until at least one
paroxysm was recorded. Hyperventilation and photic stimulation
were used as provocative methods. Patients with deﬁnite intractable
epileptic seizures (n = 50) were further subjected to brain MRI using
a high resolution 1.5 T Philips Gyroscan NI Intera. Standardised
MRI protocols consisted of (a) T1-weighted spin-echo axial images,
(b) T2-weighted turbo-spin-echo coronal images, (c) T2-weighted
turbo-spin-echo oblique coronal images, and (d) T2/Flair coronal
images. Etiological classiﬁcation was performed according to
ILAE17: genetic, structural/metabolic, and unknown.
A total of 52 of 437 patients diagnosed with epilepsy had
achieved at least 2-years seizure free with or without treatment
prior to interview. Two particularly elderly patients (aged 72 and
77 years) were excluded. The remaining 50 patients with well
controlled epilepsy were matched with the study group (Table 2)
and were chosen as a control group for statistical analysis and as a
comparison with the uncontrolled patients to identify the
predictive factors of intractability.
3.1. Data analysis
Data analysis was performed using SPSS software package
version 13. The quantitative variables were presented as the mean
and standard deviation. The qualitative variables were described
in the form of frequency and percentage. The data were analysed
for all factors separately for univariate comparisons. Standard
tests of signiﬁcance, such as chi-squared, Fisher’s exact text and
Student’s t-test were used whenever applicable, and p < 0.05 was
considered signiﬁcant. A multivariate analysis was performed
using multiple logistic regression with the forward stepwise
method to study the association between intractable epilepsy and
potential predictive factors.
Table 1
Prevalence of uncontrolled epilepsy among studied population and its proportion
among total patients with epilepsy (PWE).
Group Number % among
total PWE
N = 437
Prevalence
rate/1000
N = 62,583
CI
Total uncontrolled 134 30.60 2.1 1.77–2.5
Pseudo-intractablea 84 19.20 1.3 1.05–1.6
Deﬁnite intractable 50 11.40 0.7 0.57–1.02
a Pseudo-intractable includes non-compliance, inappropriate dose, inappropriate
AEDs, as well as psychogenic non-epileptic seizures. CI: conﬁdence interval.
Table 3
Possible aetiology of deﬁnite intractable epilepsy.
Aetiology Total
(n = 50)
< 18 years
(n = 21)
18 years
(n = 29)
No % No % No %
Presumed genetic 19 38 5 23.8 14 48.3
Structural/metabolic 23 46 10 47.6 13 44.8
Perinatal complications 6 12 5 23.8 1 3.4
Vascular lesion 6 12 – – 6 20.7
Post traumatic 3 6 – – 3 10.3
CNS infection 3 6 2 9.5 1 3.4
Congenital defects 2 4 2 9.5 – –
Tuberous sclerosis 1 2 – – 1 3.4
Mesial temporal sclerosis 2 4 1 4.8 1 3.4
Unknown 8 16 6 28.6 2 6.9
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A total of 437 patients with epilepsy were identiﬁed from the
total population. The life time prevalence was 6.98/1000, and
30.6% of these patients (n = 134/437) were uncontrolled, with a
prevalence rate of 2.1/1000. An estimation of the serum level of
AEDs revealed that only 64 patients (n = 64/134, 47.8%) had serum
levels within therapeutic ranges. Video EEG monitoring of these
cases identiﬁed ﬁfty patients (n = 50/134) with deﬁnite intractable
epilepsy, with a prevalence of 0.799 per 1000 (95% CI, 0.57–1.02)
(Table 1).
Table 2 shows the demographic data of patients with
uncontrolled epilepsy and those with controlled seizures.
Table 3 illustrates the possible aetiology of deﬁnite intractable
epilepsy. Well-deﬁned aetiologies were identiﬁed among 46% of
the patients with deﬁnite intractable epilepsy (structural/meta-
bolic cases).
Table 4 describes the univariate analysis of the suspected
factors related to seizure outcomes.
Table 5 Illustrates the logistic regression analysis of the
previously suspected risk factors of intractability. It reveals that
status epilepticus, focal seizures, and mixed types of seizures are
predictors of intractability.
5. Discussion
The magnitude of the problem of intractable epilepsy and the
long term prognosis of epileptic seizures is uncertain.26 Therefore,
the purpose of this work was to study the epidemiology of
uncontrolled epilepsy along with the hypothesis that it might be
possible to predict the outcome of epilepsy based on variables that
could be identiﬁed at the time of epilepsy diagnosis or shortly
thereafter. Such a strategy might help in individualising treatment
regimens based on the presumptive diagnosis and prognosis of
each patient.5
The proportion of diagnosed uncontrolled deﬁnite epilepsy in
this study (11.4%) (Fig. 1) was greater than that recorded by
Sillanpa¨a¨ and Schmidt27 in Finland (7%) and Berge et al.6 in
Connecticut (New England, 10%). However, it was unexpectedly
lower than that recorded by Picot et al.24 in France (15.6%) andTable 2
Demographic data of studied patients.
Variables Deﬁnite intractable
patients (N = 50)
Controlled patients
(N = 50)
Age (mean  SD) 21.5  14.7 18.6  9.6
Age at onset (mean  SD) 15.9  14.20 12.3  8.2
Sex (n and %)
Males 31 (62%) 33 (66%)
Females 19 (38%) 17 (34%)
Residence (n and %)
Rural 15 (30%) 14 (28%)
Urban 35 (70%) 36 (72%)Kwong et al.20 in China (14.2%). The discrepancy among different
studies could reﬂect true differences in the genetic predisposition
for epilepsy and the prevalence of different risk factors for the
structural/metabolic causes of epilepsy. Moreover, the proportion
of people with deﬁnite uncontrolled epilepsy (n = 50/437, 11.4%) in
our study was unexpectedly lower than that reported in developed
countries, although the deﬁnition of uncontrolled epilepsy is
restricted here (the previous 6 months); one would imagine that
this proportion (in our study) would be higher if a broader
deﬁnition was used (e.g., 18 months or two years). Thus, this
discrepancy could be attributed to the lack of a standard and well
accepted deﬁnition of intractable epilepsy in different studies.4 In a
trial to overcome this contradictory point, the application of the
ILAE criteria for patients with drug resistant epilepsy19 was made.
Accordingly, drug resistant epilepsy may be deﬁned as the failure
of adequate trials of two tolerated and appropriately chosen and
used AED schedules (whether as monotherapies or in combina-
tion) to achieve sustained seizure freedom. When applying this
deﬁnition, nearly similar results were revealed; 48 of our
diagnosed patients fulﬁlled these criteria with a 0.77/1000
(n = 48/62,583) prevalence of deﬁnite uncontrolled epilepsy, and
these patients represented 10.98% (n = 48/437) of the total number
of people with epilepsy.
Psychogenic non-epileptic seizures are sometimes misdiag-
nosed as true epileptic seizures. Previous studies found that an
estimated 5–10% of outpatients received AEDs, and approximately
20–40% of patients hospitalised for intractable epilepsy may be
suffering from psychogenic non-epileptic seizures (PNES).3,14 In
the present study, video EEG monitoring revealed that 21.9% of
patients with apparently intractable epilepsy (n = 14/64 patients)
had psychogenic non-epileptic seizures (Fig. 1). Similarly, Benbadis
and Hauser2 found that 20% of patients with apparently intractable
epilepsy had psychogenic non-epileptic seizure (PNES). However,
this rate was higher than that recorded by Smith et al.,29 who found
that 13% of refractory seizures were non epileptic. This high
proportion of psychogenic seizures as a cause of intractability may
be attributed to poor health services in this area, as there are no
neurologists and no investigatory tools, and these patients are
diagnosed and treated by general practitioners or non-specialists
with subsequent frequent miss-diagnosis. In addition, because
epileptic seizures are potentially more harmful than psychogenic
seizures, physicians tend to over diagnose epilepsy in the absence
of video EEG and even in the absence of speciﬁc EEG changes in
conventional EEG study rather than misdiagnose this serious
condition.
In this study, the rate of focal epilepsy among intractable group
(64%) was signiﬁcantly higher than those with controlled epilepsy
(26%) (Table 4). Using logistic regression analysis, focal epilepsy
still correlated signiﬁcantly with intractability (Table 5). Similarly,
Singhvi et al.28 demonstrated that 74% of intractable epileptic
Table 4
Predictors of refractory epilepsy, using univariate analysis.
Items Intractable group (N = 50) Controlled group (N = 50) Odds ratio 95% CI P value
Male sex 31 (62%) 32 (64%) 0.92 0.40–2.06 0.50
Age at onset < 1 year 11 (22%) 14 (28%) 0.72 0.29–1.8 0.322
History of status epileptics 37 (74%) 3 (6%) 44.6 11.8–168.1 0.000
Seizure frequency
Weekly or daily seizurea 43 (86%) 17 (34%) 11.9 4.4–32.1 0.000
Structural/metabolic aetiology 23 (46%) 6 (12%) 5.3 1.9–14.7 0.001
Focal seizures 32 (64%) 13 (26%) 5.5 2.3–13.1 0.000
Myoclonic seizure 7 (14%) 1 (2%) 7.9 0.9–67.4 0.030
Seizure types
Multiple seizuresb 8(16%) 1 (2%) 9.3 1.1–77 0.015
History of febrile seizure 4 (8%) 6 (12%) 0.6 0.16–2.4 0.370
Family history of epilepsy 14 (28%) 16 (32%) 0.82 0.35–1.9 0.414
Parental consanguinity 26 (52%) 11 (22%) 3.8 1.6–9.1 0.002
Mental retardation 33 (66%) 23 (46%) 2.77 1.2–6.4 0.013
a Weekly or daily seizures in case of controlled patients with epilepsy refers to the period just following the diagnosis.
b Myoclonic jerks was a component of multiple seizures in 7 out of 8 cases. Other types of seizures include focal and/or generalised seizures.
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Kwong et al.20 reported that localisation-related seizures (54.5%)
were more common than generalised onset seizures (45.5%)
among intractable epileptic patients. This signiﬁcant association
between focal epilepsy and intractability could be a reﬂection to
more structural/metabolic causes among the refractory group.
Moreover, this study demonstrated that the aetiology of
epilepsy was an important factor for determining the ultimate
prognosis of epilepsy and response to antiepileptic drugs.
Structural/metabolic epilepsy was identiﬁed in 46% of the
intractable group compared to 12% of the controlled epileptics,
and it was strongly associated with intractability, (Tables 4 and 5).
It was found that perinatal complications (23.8%, n = 5/21),
followed by CNS infections and congenital defects (9.5% for each),
were the most common causes of symptomatic intractable
epilepsy among children (<18 years), while cerebro-vascular
stroke (20.7%, n = 6/29), followed by head injury (10.3%), were the
most common causes among older age group (>18 years) (Table 3).
The lack of prenatal, perinatal, and postnatal health services might
account for the high rate of perinatal insults as a cause of
intractable epilepsy among children in this far area. These results
were in concordance with the ﬁndings of Chawla et al.9 and
Eriksson and Koivicco,13 who reported that remote symptomatic
aetiology was higher among patients with intractable epilepsy
compared to non-intractable epilepsy, and perinatal problems
(48%) were the leading cause of intractable epilepsy in childhood,
followed by central nervous system infection (24%). From another
perspective, in our study, the lower rate of perinatal problems
(23.8%) as a cause of intractability among children compared to
other studies (48%) may reﬂect higher mortality rates (compared
to morbidity rates) among those children who were victims ofTable 5
Predictors of refractory epilepsy, using logistic regression analysis.
Odds ratio 95% CI P value
History of status epilepticus 55 6.7–448.5 0.000
Seizure frequency
Weekly or daily seizuresa 2.34 0.4–12.3 0.31
Structural/metabolic aetiology 5.18 0.76–35.6 0.092
Focal seizures 12.02 2.01–70.3 0.006
Myoclonic seizures 1.48 0.012–638.2 0.881
Seizure types
Multiple seizure types 26.2 1.4–372.3 0.027
Parental consanguinity 3.05 0.63–14.6 0.163
Mental retardation 0.544 0.11–2.6 0.558
a Weekly or daily seizures in case of controlled patients with epilepsy refers to the
period just following the diagnosis.perinatal insults caused by the lack of proper health services in this
area.
Using a univariate analysis to evaluate the predictive factors of
intractability revealed that myoclonic jerks was an independent
risk factor for intractability (Table 4). However, this result was not
apparent when using logistic regression analysis. Only when
associated with other types of seizures (multiple seizure types) did
myoclonic jerks become a strong predictor for intractability,
(Table 5). This result was in agreement with Eriksson and
Koivicco13 and Chawla et al.9 on the contrary, Camﬁeld et al.8
did not ﬁnd seizure type to be a predictor of intractability, even in a
univariate analysis. The association of mixed seizure types with
poor outcome may be attributed to the pathophysiology of the
disease itself. However, it may reﬂect misdiagnosis, as physicians
might not ask about detailed semiology of seizures. This
misdiagnosis of other seizures in the same patient will lead to
inappropriate AED choices and intractability.
This study reported high seizure frequencies among 86% of
intractable cases (68% had weekly seizures, and 18% had daily
seizures), and in the univariate analysis, this high seizure
frequency was signiﬁcantly associated with intractability. More-
over, there was a signiﬁcant association between status epilepti-
cus (SE) and seizure intractability, as demonstrated by both
univariate and logistic regression analyses. In this respect, our
ﬁndings were in agreement with Ohtsuka et al.23 and Malik et al.21
who found a similar signiﬁcant association between SE and
intractability. Conversely, AKhondian et al.1 found no similar
association. The high rate of SE and the high seizure frequency
among intractable patients in our study may be attributed to the
high proportion of structural/metabolic and unknown causes
among our studied patients (62%). Moreover, the lack of proper
health services in this area, in addition to the false ﬁxed beliefs
about epilepsy (evil attack), might delay medical consultation and
result in further repeated seizures, more brain damage and the
enhancement of epileptogenesis, thereby leading to further
intractability. Thus, the relationship between SE and intractability
could be explained in a cause and effect manner in which
intractability leads to more seizure frequency and SE, and both SE
and intractability lead to more brain damage, epileptogenesis and
further intractability.
In this study, mental sub-normality (IQ < 67) was detected in
66% of deﬁnite intractable patients. Similar results were reported
by Huttenlocher and Hapke15 in USA who found mental retarda-
tion in 61% of intractable patients. This signiﬁcant high risk of
cognitive impairment in the intractable group may be attributed to
several factors, including the underlying aetiology, the effect of the
uncontrolled seizures, and/or AED side effects.
Fig. 1. Algorithm of the outcome of this study.
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from remission failure. Failure to enter into remission may be
attributed to numerous factors, including the lack of treatment,
improper diagnosis, poor drug compliance, and/or inappropriate
AED prescriptions. Therefore, proper diagnosis and the availability
of health services and AEDs, together with improved general
knowledge about epilepsy, could be factors that affect the
reduction of remission failure and/or intractability.
6. Conclusions
1. The prevalence of deﬁnite intractable epilepsy in Al-Kharga
District, New Valley (Egypt) was 0.7/1000.
2. Status epilepticus, focal seizures, and mixed seizure types are
consistent predictors of the reduced probability of remission, or
even intractability.
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